Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Sales rise but profits fall at J&J in Q3

Failed clinical programmes and Synthes acquisition hit net results

- PMLiVE

Novo Nordisk files new haemophilia drug in EU, US

Seeks approval for turoctocog alfa shortly after vatreptacog alfa pulled

- PMLiVE

EC health commissioner John Dalli resigns after anti-fraud case

Linked to attempt to influence tobacco policy

Open Health adds pH Associates to its roster

UK real world data specialist will bolster Open's market access offering

- PMLiVE

RSA appoints Dr Francois Martin to lead Swiss operation

He joins the company from the International Executive Search Federation

- PMLiVE

Amgen’s Anna Richo joins UCB as executive VP and general counsel

Meanwhile, Cynthia Patton takes over as Amgen’s senior VP and chief compliance officer

- PMLiVE

GSK reverses closure of Irish manufacturing facility

But will initially cut staff numbers at Stiefel's Sligo plant by a third

Pilot study combines patient-reported outcomes and medical records

Quintiles concludes patients can be recruited directly for observational studies

- PMLiVE

Merck & Co pays €110m upfront for AiCuris’ CMV portfolio

Lead candidate is orphan drug letermovir for transplant patients

- PMLiVE

Lilly’s gastric cancer prospect clears phase III trial

Ramucirumab improved both overall and progress-free survival

Roche - Basel

Roche Q3 sales up on cancer drugs

And CEO Schwan commits to gene sequencing despite failed Illumina bid

- PMLiVE

Woolley Pau Gyro appoints Andy Jones as creative director

The appointment sees founder Dean Woolley becomes executive creative director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links